Dachaigh › Luchd-obrach › AARKISH Pharmaceuticals NJ, Inc.
AARKISH Pharmaceuticals NJ, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir AARKISH Pharmaceuticals NJ, Inc. 18 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 14. Tuarastal meadhanach a chaidh a thabhann: $73,800.
A bheil AARKISH Pharmaceuticals NJ, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir AARKISH Pharmaceuticals NJ, Inc. 18 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 5 Samh 2025. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Formulation Scientist | 6 | $67,900 |
| Quality Control Analyst | 4 | $101,764 |
| Quality Control Chemist | 2 | $67,000 |
| Quality Assurance Specialist | 2 | $60,600 |
| Pharmaceuticals Sales Representative | 2 | $75,000 |
| Quality Assurance Chemist | 1 | $80,000 |
| Quality Assurance/Regulatory Affairs Senior Analyst | 1 | $78,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 3 | $72,000 |
| FY2024 | 3 | $80,000 |
| FY2025 | 9 | $63,200 |
| FY2026 | 3 | $101,764 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Chemists13
- Regulatory Affairs Specialists3
- Sales Representatives, Wholesale and Manufacturing, Technical and Scientific Products2
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Formulation Scientist | $85,450 Ìre II | Fairfield, NJ | 5 Samh 2025 | 4 Gibl 2026 | Dearbhaichte |
| Quality Control Analyst | $101,764 Ìre II | Fairfield, NJ | 24 Sult 2025 | 12 Dàmh 2025 | Dearbhaichte |
| Quality Control Analyst | $101,764 Ìre II | Fairfield, NJ | 24 Sult 2025 | 12 Dàmh 2025 | Dearbhaichte |
| Quality Control Analyst | $101,764 Ìre II | Fairfiled, NJ | 24 Sult 2025 | 12 Dàmh 2025 | Air a tharraing air ais |
| Quality Assurance Specialist | $60,600 Ìre I | Fairfield, NJ | 5 Ògmh 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Quality Assurance Specialist | $60,600 Ìre I | Fairfield, NJ | 5 Ògmh 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Formulation Scientist | $63,200 Ìre I | Fairfield, NJ | 5 Ògmh 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Formulation Scientist | $63,200 Ìre I | Fairfield, NJ | 5 Ògmh 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Pharmaceuticals Sales Representative | $75,000 Ìre I | Fairfield, NJ | 5 Ògmh 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Formulation Scientist | $63,086 Ìre I | Fairfield, NJ | 4 Ògmh 2025 | 1 Dàmh 2025 | Air a tharraing air ais |
| Pharmaceuticals Sales Representative | $74,589 Ìre I | Fairfield, NJ | 4 Ògmh 2025 | 1 Dàmh 2025 | Air a tharraing air ais |
| Formulation Scientist | $63,086 Ìre I | Fairfield, NJ | 4 Ògmh 2025 | 1 Dàmh 2025 | Air a tharraing air ais |
| Quality Assurance/Regulatory Affairs Senior Analyst | $78,000 Ìre II | Fairfield, NJ | 18 Sult 2024 | 7 Dàmh 2024 | Dearbhaichte |
| Quality Assurance Chemist | $80,000 Ìre II | Fairfield, NJ | 12 Faoi 2024 | 12 Gearr 2024 | Dearbhaichte |
| Quality Control Analyst | $95,000 Ìre II | Fairfield, NJ | 9 Samh 2023 | 15 Gearr 2024 | Dearbhaichte |
| Quality Control Chemist | $72,000 Ìre I | Fairfield, NJ | 10 Cèit 2023 | 1 Dàmh 2023 | Dearbhaichte |
| Quality Control Chemist | $62,000 Ìre I | Fairfield, NJ | 31 Màrt 2023 | 24 Gibl 2023 | Dearbhaichte |
| Formulation Scientist | $72,600 Ìre I | Fairfield, NJ | 15 Màrt 2023 | 4 Gibl 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).